FIGURE
Figure 4
- ID
- ZDB-FIG-221031-189
- Publication
- English et al., 2022 - Next-Generation SINE Compound KPT-8602 Ameliorates Dystrophic Pathology in Zebrafish and Mouse Models of DMD
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 4
KPT−8602 reduces osteopontin serum levels in D2-mdx mice. Osteopontin (OPN) in circulating serum levels was assessed by ELISA assay. KPT−8602 (5x/week) treatment significantly reduced osteopontin levels compared to vehicle-treated D2-mdx, demonstrating levels comparable to WT mice (data is presented as mean ± SEM, n = 4–5 mice per cohort; * p < 0.05, ** p < 0.01; one-way ANOVA with Tukey’s HSD test). |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biomedicines